(Q33958344)

30 July 2017

1 reference

title

Depression in patients with cardiac disease: a practical review (English)

1 reference

30 July 2017

1 reference

Lespérance F

1

1 reference

30 July 2017

Frasure-Smith N

series ordinal

2

1 reference

30 July 2017

publication date

1 April 2000

1 reference

Journal of Psychosomatic Research

30 July 2017

published in

1 reference

30 July 2017

volume

48

1 reference

30 July 2017

issue

4-5

1 reference

30 July 2017

page(s)

379-391

1 reference

Major depression before and after myocardial infarction: its nature and consequences

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depression following myocardial infarction. Impact on 6-month survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depression and 18-month prognosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depression in hospitalized older patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Major depressive disorder in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Underdiagnosis of depression in patients with coronary artery disease: the role of nonspecific symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Association of depression with 10-year poststroke mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depressive symptoms and increased risk of stroke mortality over a 29-year period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

A systematic review of the mortality of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depression and the course of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Role of psycho-social factors in CVD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Are we mortgaging the medical profession?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Serotonin 5-HT2 receptor binding on blood platelets--a peripheral marker for depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Further studies on platelet serotonin transporter binding in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Exaggerated platelet reactivity in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Evidence of a Selective Increase in Cardiac Sympathetic Activity in Patients with Sustained Ventricular Arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Time domain measurements of heart rate variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Association of depression with reduced heart rate variability in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Disability and depression among high utilizers of health care. A longitudinal analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Health care costs of primary care patients with recognized depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

The many faces of depression following spousal bereavement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health specialty outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Subsyndromal ("mixed") anxiety--depression in primary care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Toward a scientific psychiatric nosology. Strengths and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Cardiovascular risk factors in depression. The role of anxiety and anger.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

'Vascular depression' hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Arteriosclerotic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

The depression-dementia conundrum: integrating clinical and epidemiological perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

An Inventory for Measuring Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

All roads lead to depression: clinically homogeneous, etiologically heterogeneous

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Recovery and major depression: factors associated with twelve-month outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Selections from current literature: minor depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depression in patients with coronary heart disease. A 12-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

The relationship between major and subthreshold variants of unipolar depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depressive symptoms as relative and attributable risk factors for first-onset major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Relapse of depression in primary care. Rate and clinical predictors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Residual symptoms after partial remission: an important outcome in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Recovery From Major Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Major depression and generalized anxiety disorder. Same genes, (partly) different environments?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Diagnosis and outcome: depression and anxiety in a general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Comorbidity of personality disorders and unipolar major depression: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Effects of social support and personal coping resources on depressive symptoms: Different for various chronic diseases?

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

7 January 2021

THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Stress and depression: a test of the buffering model of social support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Social support and the outcome of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

A population-based twin study of lifetime major depression in men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Cardiovascular effects of fluoxetine in depressed patients with heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

National Institute of Mental Health Treatment of Depression Collaborative Research Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Differential relapse following cognitive therapy and pharmacotherapy for depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Psychopharmacologic treatment of depression in the medically ill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

The emerging role of cytochrome P450 3A in psychopharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Newer antidepressants and the cytochrome P450 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Cognitive Therapy and Pharmacotherapy for Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Cigarette smoking: implications for psychiatric illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Smoking, smoking cessation, and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Major depression and stages of smoking. A longitudinal investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

A comparison of sustained-release bupropion and placebo for smoking cessation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Psychiatry and cigarettes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

Depression and cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

7 January 2021

Major depression and medication adherence in elderly patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

7 January 2021

Social support, coping, and depressive symptoms in a late-middle-aged sample of patients reporting cardiac illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2899%2900102-6

7 January 2021

10.1016/S0022-3999(99)00102-6

Identifiers

DOI

1 reference

30 July 2017

1 reference